More tools:Markets·Screener·Research·Chat

HeartSciences Inc. Common Stock (HSCS) Financial Statements

HeartSciences Inc. Common Stock
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI BBG0185L0106
XNAS · usd
3.96▼ 0.12 (-2.94%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close4.08
Day's Range3.91 – 4.35
52-Week Range1.63 – 4.35
Volume287.7K
Avg Volume118.8K
Share Statistics
Shares Outstanding
Employees12
ExchangeXNAS
Listed2022-06-15
Share count as of July 20, 2026
Loading Income Statement…
Key questions about HeartSciences Inc. Common Stock (HSCS)
What is HeartSciences Inc. Common Stock's Market Cap?
HeartSciences Inc. Common Stock's Market Cap is $15.4M, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's Enterprise Value?
HeartSciences Inc. Common Stock's Enterprise Value is $13.7M, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's Price / Sales?
HeartSciences Inc. Common Stock's Price / Sales is 3575.4×, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's EV / Revenue?
HeartSciences Inc. Common Stock's EV / Revenue is 3181.8×, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's EV / EBITDA?
HeartSciences Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's Revenue (TTM)?
HeartSciences Inc. Common Stock's Revenue (TTM) is $4.3K, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's Net Income (TTM)?
HeartSciences Inc. Common Stock's Net Income (TTM) is -$9.1M, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's EBITDA?
HeartSciences Inc. Common Stock's EBITDA is -$8.4M, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's Diluted EPS (TTM)?
HeartSciences Inc. Common Stock's Diluted EPS (TTM) is -2.34, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's EBITDA Margin?
HeartSciences Inc. Common Stock's EBITDA Margin is -194143.9%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemApr 30, 2026Jan 31, 2026Oct 31, 2025Jul 31, 2025Apr 30, 2025Jan 31, 2025Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022
Revenue
YoY growth-100.0%———
Cost of sales
Gross margin
% of revenue——58.3%60.0%
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
% of revenue——85771.6%98697.8%
Loss from operations
% of revenue——-85713.2%-98637.8%
Other income (expense)
Interest expense
Other income
Total other expense
Net loss
% of revenue——-97179.4%-108157.6%
Net loss per share, basic and diluted (in dollars per share)